HKEx Resumption Guidelines 2026: September 2026 Amendment

The Hong Kong Stock Exchange (HKEx) has amended Guidance Letter HKEX-GL95-18 (GL95-18) to require an independent adviser — not the issuer’s directors — to opine on the adequacy and effectiveness of internal control measures for long-suspended issuers. The 18-month delisting clock under Listing Rule 6.01A(1) remains absolute, does not pause, and does not reset. Courts have consistently refused to rescue issuers from their own delays. Satisfying HKEx resumption conditions is necessary but, where the SFC has separately suspended trading under Section 8 SMLR, not sufficient. The regulatory toolkit now includes post-listing conditions as a less disruptive alternative to prolonged suspension, but the margin for error has never been narrower.

Takeaways

• Independent internal control reviews are now mandatory. Director self-certification is gone. The evidentiary burden has shifted to third-party professionals.
• The 18-month clock is hard, not soft. It runs from the date of suspension, not from the date of any resumption guidance letter.
• The “fast track” delisting risk is real. The Exchange can move from Show Cause Letter to Listing Committee decision in a matter of days, as the Dashan Education case illustrates.
• SFC Section 8 suspensions create a two-front battle. HKEx resumption conditions and SFC investigation clearance must both be satisfied.
• Day 1 mobilisation. Every day of the 18 months counts.

Evolution of GL95-18: From PN17 to the Hard Clock

Before 2018: The “Zombie” Era

Prior to 2018, Hong Kong’s delisting framework operated under Practice Note 17 (PN17), a three-stage process that allowed suspended companies to languish in a “zombie” state for years, submitting endless unviable resumption proposals while trapping minority investors’ capital. The process lacked a hard deadline, and delisting was a lengthy, uncertain process.

2017 Consultation and Rule 6.01A

The HKEx launched a consultation in 2017, culminating in the introduction of Listing Rule 6.01A on 1 August 2018. The amended Rule provides that the HKEx may cancel the listing of a Main Board issuer that has been suspended from trading for a continuous period of 18 months (12 months for GEM) and has failed to remedy the issues causing the suspension and resume trading.

GL95-18 was published as the operational guidance letter accompanying the new Rule. Its stated objective is “to keep the necessary trading suspension to the minimum, by facilitating timely delisting of issuers that no longer meet the continuing listing criteria.”

18-Month Clock: What It Actually Means

The 18-month period runs from the date of suspension, not from the date of any resumption guidance letter. The clock does not pause, and it does not reset. Extensions are granted only in “exceptional circumstances” under paragraph 19 of GL95-18 — where the issuer has taken concrete steps and has a high degree of certainty of resuming trading, but needs a short extension due to factors not within its control (generally expected to be procedural matters only).

In practice, an extension is generally granted only once, and further extensions are rarely approved.

Market Data

As at 31 August 2026, 31 companies had been delisted year-to-date (23 Main Board, 8 GEM). These demonstrate that the HKEx is enforcing the 18-month deadline with vigour.

The September 2026 Amendments:

What Actually Changed

The September 2026 amendments to GL95-18 are centred on internal control reviews. The Exchange now strictly requires an independent adviser to opine on the adequacy and effectiveness of internal control measures, rather than accepting self-certification by the issuer or its directors. This is not merely a procedural tightening — it fundamentally shifts the evidentiary burden from the issuer’s directors to independent third-party professionals.

The SFC’s March 2026 Review Report: The Catalyst

The amendments were driven by the SFC’s review report published in March 2026, which assessed the Exchange’s regulation of listing matters. The SFC’s core concern was that the Exchange had been overly reliant on directors’ self-certifications regarding the adequacy of internal controls. This approach posed an inherent conflict of interest: directors whose own conduct may have contributed to the suspension were being asked to confirm that remedial measures were adequate.

Substantive, Not Procedural

Consistent with the reasoning in Boill Healthcare Holdings Ltd v The Stock Exchange of Hong Kong Ltd [2026] HKCFI 3827, internal control reviews must address substantive issues — not merely complete procedural steps. The court noted that fulfilling resumption guidance involves addressing management integrity and demonstrating compliance with Rule 13.24.

The HKEx has also reiterated that the 18-month mark is the deadline for the actual resumption of trading — meaning all forensic investigations, internal control reviews, and audit clearances must be fully completed and approved well before the clock expires.

“No Reset”

The “no resetting the clock” principle remains absolute: if the HKEx uncovers further irregularities during the suspension period and imposes new resumption conditions, the addition of these conditions does not entitle the issuer to an extension of the original 18-month deadline.

Dashan Education Precedent

Dashan Education Holdings Limited (9986.HK) case illustrates a critical strategic risk that suspended issuers must confront. On 9 March 2026, the Listing Division determined that the company’s 2024 resumption had been “based on materially inaccurate information” and “should not have occurred,” and initiated the fast track delisting procedure.

On 4 June 2026, the Listing Committee decided to cancel Dashan’s listing with effect from 23 June 2026. The Listing Committee meeting was attended only by the Listing Division; the company was not present and had no opportunity to make oral representations. The Listing Division had notified the company of the proposed delisting on 1 June, just three days before the Listing Committee meeting.

The company challenged the decision on the basis, among others, that the fast track procedure unjustly circumvented its statutory right under Section 9 of the SMLR to make representations in respect of the SFC’s Section 8 suspension order. The company also argued that GL95-18 fast track delisting is typically reserved for exceptional circumstances such as a court finding of fraud — and in this case, no such finding existed, with both the independent forensic investigation and the SFC investigation still ongoing.

The Listing Review Committee heard the review on 19 August 2026 and, rather than upholding or overturning the decision, granted the company more time to submit its forensic report. The matter remains unresolved as of September 2026.

What This Means for Issuers

• Listing Division can act with extreme speed. The window between notification and decision can be measured in days, not months.
• Companies that previously resumed trading are not safe. If the HKEx subsequently determines that a prior resumption was based on inadequate disclosure, it can revisit the matter and initiate fast track delisting.
• Right to be heard is contested. The extent to which Section 9 SMLR procedural rights must be respected before HKEx delisting action is now a live legal question.
• The “exceptional circumstances” threshold is being tested. Whether fast track delisting can be invoked in the absence of a court finding of fraud is now before the Listing Review Committee.
• Issuers and their advisers must prepare for the possibility that the Exchange may seek to delist without a full oral hearing, and must ensure that all submissions are made in writing at the earliest opportunity.

Judicial Decisions

Issuers facing imminent delisting have increasingly turned to the High Court, seeking judicial review (JR) to challenge the Listing Committee’s refusal to grant deadline extensions. The legal precedent is firmly established: the courts will not save a company from its own delays.

• Bolina Holding Co Ltd (in liquidation) v The Stock Exchange of Hong Kong Ltd [2021] HKCFI 460: The High Court dismissed Bolina’s application for leave to apply for judicial review of the Listing Review Committee’s decision to cancel its listing. The court accepted that the resumption conditions all carried equal weight and that partial compliance (or claiming delays due to COVID-19) did not constitute “exceptional circumstances.”
• Brightoil Petroleum (Holdings) Ltd v The Stock Exchange of Hong Kong Ltd [2020] HKCFI 1601: Brightoil challenged the Listing Committee’s decisions to cancel its listing and refuse an extension of time. The court dismissed the application, confirming that the availability of a de novo review by the Listing Review Committee constituted an adequate alternative remedy, undermining claims of procedural unfairness.
• China Trends Holdings Ltd v The Stock Exchange of Hong Kong Ltd [2026] HKCA 95: The Court of Appeal dismissed China Trends’ appeal against the refusal of leave to apply for judicial review regarding Rule 13.24 compliance. The court emphasised the profound deference owed to the Exchange’s evaluative judgment, confirming that the assessment of business viability is a qualitative test for the Exchange’s specialist committees, not the courts.

What the Courts Have Made Clear

• Internal failures do not count. Disputes with former management, delays by forensic accountants, complexities in debt restructuring, or difficulties in recovering documents are inherent risks of corporate distress, not exceptional circumstances.
• Public interest prevails. Judges have confirmed that market certainty outweighs the private commercial interests of the suspended company and its creditors.

The SFC Overlay: Section 8 SMLR Suspensions

While GL95-18 governs HKEx-mandated suspensions, issuers must be highly alert to the Securities and Futures (Stock Market Listing) Rules (SMLR). If the SFC directs a suspension under Section 8 of the SMLR (typically for suspected fraud, fabricated revenues, or false disclosures), the issuer is fighting a two-front war. Satisfying the HKEx’s resumption conditions under GL95-18 is necessary but not sufficient in these cases. The issuer must concurrently satisfy the SFC’s separate investigation.

Post-Listing Conditions

The SFC has proposed amendments to the SMLR that would expressly allow it to impose post-listing conditions on issuers as an alternative to suspension, requiring more transparent and complete disclosures without disrupting trading. The proposals also include simplifying trading resumption procedures to shorten suspension time.

These amendments are significant for suspended issuers. If enacted, they would provide a regulatory pathway that avoids the binary choice between full resumption and delisting. The SFC has completed the consultation and plans to submit the amended subsidiary legislation to the Legislative Council for negative vetting within 2026. Issuers facing SMLR suspension should monitor these developments closely: the availability of post-listing conditions as an alternative may materially affect the strategic calculus.

The AFRC-SFC MoU: Enhanced Regulatory Cooperation

On 28 September 2026, the Accounting and Financial Reporting Council (AFRC) and the SFC entered into a new Memorandum of Understanding (MoU) that expands regulatory cooperation beyond the oversight of financial reporting and related audit work of listed entities.

The new MoU establishes a comprehensive framework for information sharing, case referrals, mutual assistance, and coordinated inspections and investigations. For suspended issuers, this MoU signals that the AFRC and SFC will coordinate more closely on financial reporting and audit-related matters. Issuers undergoing forensic investigations should expect that audit quality and financial reporting integrity will be subject to heightened scrutiny from both regulators.

Strategic Implications and Opportunities

For Listed Issuers and Boards of Directors

• Day 1 Mobilisation: If a suspension involves accounting irregularities, an Independent Board Committee (IBC) must be formed immediately. Waiting weeks to appoint forensic accountants and legal counsel could lead to failure. 
• Independent Internal Control Advisers: The September 2026 amendments mean self-certification is gone. Issuers must engage independent professional advisers with the expertise to produce a review the Exchange will accept.
• Prepare for Fast Track: Do not assume that the HKEx will follow a leisurely process. The Dashan Education case shows that the Listing Division can move from notification to Listing Committee decision in a matter of days. Ensure that all submissions are made in writing and that the record is complete at the earliest possible stage.
• Dual-Track Restructuring: For financially distressed issuers, debt restructuring negotiations must run concurrently with the forensic and audit cleanup. Creditors will not agree to a debt-for-equity swap if the underlying equity is months away from being cancelled.

For Private Equity, VC Funds, and “White Knights”

• Distressed M&A Leverage: The strict 18-month clock forces the hands of legacy controllers. They would be motivated to accept aggressive valuation haircuts and loss of control in exchange for rescue capital before their equity value drops to zero.
• Structuring the Rescue: Injecting assets into a suspended company requires navigating the Reverse Takeover (RTO) rules while simultaneously satisfying GL95-18 resumption conditions. Acquirers must ring-fence legacy liabilities to present a “clean” vehicle to the Listing Committee before the deadline expires.

Resumption is a high-stakes, time-barred regulatory defence project. In the current regulatory environment, substantive remediation capability — executed immediately by independent professionals — is the singular factor in determining the success or failure of a resumption application.  Contact us for a confidential assessment and assist with full resumption process.